SCHEMBL6515050

SCHEMBL6515050

CC(=O)COC(=O)/C=C/C(=O)OCC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 7/20 0.46
ATM Q13315 1/20 0.46
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
MAPT P10636 7/20 0.38
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MDM4 O15151 1/20 0.35
MDM2 Q00987 1/20 0.35
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CES2 O00748 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6518970 0.91 HCAR2 (0.61) HCAR2ATMMAPTALDH1A1LMNA
SCHEMBL27806191 0.91 HCAR2 (0.61) HCAR2ATMMAPTALDH1A1LMNA
SCHEMBL2627702 0.91 HCAR2 (0.59) HCAR2ATMKEAP1NFE2L2MAPT
SCHEMBL18288662 0.89 PKM (0.41) HCAR2ATMKEAP1NFE2L2MAPT
SCHEMBL10024386 0.87 GSTP1 (0.39) HCAR2ATMKEAP1NFE2L2MAPT
SCHEMBL6524294 0.85 ATM (0.45) HCAR2ATMKEAP1NFE2L2MAPT
SCHEMBL10947716 0.81
SCHEMBL9464814 0.80 HCAR2 (0.40) HCAR2ATMKEAP1NFE2L2MAPT
SCHEMBL27327529 0.80 AKT1 (0.41) HCAR2ATMKEAP1NFE2L2MAPT
SCHEMBL868205 0.79 HCAR2 (0.43) HCAR2ATMKEAP1NFE2L2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119707897-A Process for preparing michelia lactone derivatives 鄂尔多斯市尚德艾康药业有限公司 2025-03-28 CN disclosed
CN-113966330-A Crystalline form S4 of the PLK4 inhibitor (1R,2S) - (E) -2- (3- (4- ((cis-2, 6-dimethylmorpholine) methyl) styryl) -1H-imidazol-6-yl) -5 ' -methoxyspiro [ cyclopropane-l, 3 ' -indolin ] -2 ' -one fumarate 大学健康网络 2022-01-21 CN disclosed
EP-3813835-A1 SALTS OF (S)-(5-CYCLOBUTOXY-2-METHYL-6-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)(CYCLOPROPYL)METHANONE AND SOLID FORMS THEREOF Forma Therapeutics, Inc. (US) 2021-05-05 EP disclosed
CN-108349978-A Solid forms and formulations of (S) -4- (8-amino-3- (1- (but-2-ynoyl) pyrrolidin-2-yl) imidazo [1,5-a ] pyrazin-1-yl) -N- (pyridin-2-yl) benzamide 安塞塔制药公司 2018-07-31 CN disclosed
US-6958366-B2 Antifouling coating composition and novel resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2005-10-25 US disclosed
US-20030118544-A1 Antifouling coating composition and novel resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-06-26 US disclosed
CN-87106804-A Imidazopyridine derivatives, the pharmaceutical compositions that contains imidazopyridine derivatives and their preparation method 1988-05-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118544-A1 Antifouling coating composition and novel resin COL1A1, GLRA1, COL2A1 HCAR2 3143/4885ATM 4559/4885KEAP1 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.